Tonia S. Afshan, MD, MPH, FAAP

Dr. Afshan specializes in assessment and treatment of allergic and immunologic conditions, including food allergy, allergic rhinitis, atopic dermatitis, asthma, insect allergy, drug allergy, urticaria, and immunodeficiency. She strives for clear and open communication with patients and families, their primary care providers, and other specialists that are a part of their medical team. She greatly enjoys working closely with patients and families on food introduction and allergy prevention, skin care, and a variety of other interventions that can have significant and meaningful impacts on everyday life.

Personal Statement

I aim to work with patients and families to provide cost-effective, evidence-based medical care through shared decision making and collaboration. I am committed to being a reliable resource for medical information and education that patients and families can turn to when they have questions or concerns. My goal for all my patients is that they be able to safely do everything they want in life despite their allergic or immunologic conditions.

Clinical Interests

Food allergy, atopic dermatitis, drug allergy, immunodeficiency

Education

Organizations

Board Certifications

American Board of Pediatrics

American Board of Allergy and Immunology

Honors and awards

2022-2023

Chief Fellow, University of Wisconsin Allergy/Immunology Fellowship Program

2020

Alpha Omega Alpha, Michigan State University

* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.

Research interests

Penicillin/drug allergy delabeling, global health, quality improvement, medical education

Publications

Antara, A., Afshan, T., VanSickle, E., Michael, J., Laarman, R., Bupp, C. "Improvement of Dermatological Symptoms in Patients with Bachmann-Bupp Syndrome using Difluoromethylornithine Treatment." Pediatric Dermatology, June 2022

Afshan, T., Kulkarni, A., Smith, J.M., Tesson, E., Blackshere, T., Joseph, C., Zoratti, E., Rivera-Spoljaric, K., Hartert, T., Gern, J.E., Singh, A.M. "Research Protocol and Recruitment Redesign of a Study of Pregnant Women and their Infants during the COVID-19 Pandemic: Childhood Allergy and the NeOnatal Environment (CANOE)." JACI: Global, February 2024.

Notable presentations

Afshan, T., Timberlake, D., Schauberger, E. “Evaluation and Management of Delayed Hypersensitivity Reaction to Insulin in an Adolescent Patient.” American College of Allergy, Asthma, and Immunology, Louisville, KY. November 2022.

Afshan, T., Schauberger, E., Gern, J., Seroogy, C. “Keeping a Broad Differential Diagnosis: Pancytopenia and Inconclusive Newborn Screen for SCID.” American Academy of Allergy, Asthma, and Immunology, Phoenix, AZ. February 2022.

Afshan, T., Kelbel, T. “Urticaria Multiforme: To Challenge or Not Challenge, That Is The Question...” American College of Allergy, Asthma, and Immunology, New Orleans, LA. November 2021.

Afshan, T., Faybusovich, P., Craig, T., Kelbel, T. “Lanadelumab as Treatment for Acquired Angioedema with Low C1-inhibitor, a 3-patient Case Series.” American Academy of Allergy, Asthma, and Immunology, virtual conference. February 2021.

Afshan, T., Hartog, N. “CTLA-4 Haploinsufficiency-associated Psoriasis, Lymphadenopathy, and Neutropenia Successfully Treated with abatacept.” American College of Allergy, Asthma, and Immunology, virtual conference. November 2020.